NEWS COMMENTARY

Ascus Biosciences uses its livestock microbiome expertise to raise a $46 million Series B

Published:
May 28, 2020
Services:
Consumer
Activities:
Investment
Very important

The funding round was led by Temasek Holdings and included investors Anterra Capital, Formation 8, Cavallo Ventures, and others. Ascus Biosciences develops microbe-based animal health products using bioinformatics and computer science rather than the chemistry-based approaches traditionally used in the feed additives industry. The company will use the funding to support its sales and service teams as well as for R&D. This news highlights just how significant understanding of the underlying physiological impacts of microbial products in livestock feeding is becoming to drive innovation in animal health. Clients should recognize how testing product performance using in silico experimentation is as important as livestock feeding trials.

For the original news article, click here .


Further Reading

Evolve BioSystems raises $55 million to expand its probiotics for infant health application

News Commentary | February 12, 2021

This Series D funding round was led by Cargill and Manna Tree and will help Evolve expand the market reach of its probiotic supplement targeting infant health. This investment also signals Cargill's sustained interest in the microbiome space, coming on the heels of its previous investment in ... To read more, click here.

Inbiose adds another €15 million to bring new HMOs to market

News Commentary | July 22, 2021

Inbiose received this funding in the form of a loan from the European Investment Bank (EIB), helping the company scale up production for other new HMOs beyond 2’‑fucosyllactose. In line with its commercialization plans, Inbiose recently submitted applications for FDA's regulatory approval covering ... Not part of subscription

Nature's Fynd set to construct new manufacturing facility in Chicago and launch products locally

News Commentary | November 11, 2021

The expansion follows $350 million Series C funding in July and will see the company construct a 200,000 ft2 facility in Chicago — adding 200 staff to its workforce for a total of 350 by 2023. Its recent launch of a cream cheese spread and sausage patties distinguishes it from most alternative ... Not part of subscription